Swiss pharmaceutical company founded in 1945, known for therapeutic products in urology, reproductive medicine, and dermatology, headquartered in Lugano, Switzerland.
Company Type
private
Founded
1945
Headquarters
Lugano, Switzerland
Stock
N/A: N/A
Revenue
approximately CHF 800 million (FY2024)
Employees
approximately 2,000
Primary Market
Global
Swiss pharmaceutical company founded in 1945, known for therapeutic products in urology, reproductive medicine, and dermatology, headquartered in Lugano, Switzerland.
IBSA was founded in 1945 by Dott. Angelo Cavalli in Lugano, Switzerland. The company started as a biochemical research institute focusing on pharmaceutical research and development. Cavalli wanted to create a company that would develop innovative pharmaceutical products. The company grew through research and development and international expansion.
In the 1960s and 1970s, IBSA expanded its product portfolio and international presence. The company developed innovative drug delivery systems including transdermal patches and oral sprays. IBSA also expanded into international markets, establishing operations in Europe and other regions. The company became known for its expertise in drug delivery technology.
In the 1980s and 1990s, IBSA focused on specialty pharmaceuticals in urology, reproductive medicine, and dermatology. The company developed products for urological conditions, fertility treatments, and dermatological conditions. IBSA also invested in manufacturing capabilities and research and development.
In the 2000s and 2010s, IBSA continued to expand its international presence and product portfolio. The company established operations in Asia, the Americas, and other regions. IBSA also developed new drug delivery systems and therapeutic products. The company has maintained its focus on specialty pharmaceuticals and innovative drug delivery.
Recent strategic direction has focused on drug delivery innovation and international expansion. IBSA has invested in new drug delivery technologies and expanded its presence in emerging markets. The company has also focused on research and development in urology, reproductive medicine, and dermatology. IBSA continues to innovate in specialty pharmaceuticals.
IBSA Institut Biochimique S.A. owns 0 brands in our database.
June 2026 was the most historic IPO month in market history: SpaceX priced at $135 per share on June 12, raising $75 billion in the largest IPO ever. Quantinuum raised $1.68B, INNIO priced a $2.8B deal, and Bending Spoons filed for a $20B Nasdaq listing. Full recap.
June 2026's biggest brand ownership moves: Berkshire Hathaway agreed to buy Taylor Morrison for $6.8B, GSK struck a $10.6B deal for Nuvalent, CRH acquired Arcosa for $8.5B, and Qualcomm agreed to buy AI startup Modular for $3.92B. Full breakdown of every major deal.
LVMH owns 75 luxury maisons including Louis Vuitton, Dior, Tiffany, Guerlain, and Sephora. Here is the complete brand list by division, with acquisition dates and what each brand does.

Swiss luxury watch manufacturer founded in 1846, known for marine chronometers and luxury watches, headquartered in Le Locle, Switzerland.
1 brand in portfolio

Password management software company providing secure password storage, sharing, and digital identity solutions for individuals and businesses.
0 brands in portfolio

American cloud collaboration service company providing spreadsheet-database hybrid platform for data organization and management.
1 brand in portfolio

American brand management company that acquires and licenses consumer brands across fashion, sports, entertainment, and lifestyle categories, headquartered in New York City.
13 brands in portfolio

Private American web software company operating WordPress.com, WooCommerce, Tumblr, and other publishing and e-commerce platforms globally.
1 brand in portfolio

International music company owned by Bertelsmann, operating in music publishing, recorded music, and artist management with headquarters in Berlin.
2 brands in portfolio